Sol-Gel Technologies Ltd. (SLGL)
NGM · Common · CUSIP M8694L103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for SLGL and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
M8694L103
Market Cap
Micro Cap
IPO
2/1/2018 · $12.00/share
Business: Sol-Gel Technologies Ltd. Is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.
Notes: May 01, 2025 -- Sol-Gel Technologies Ltd. (the “Company”) (NASDAQ: SLGL), a clinical-stage dermatology company, today announced a reverse share split (the “Reverse Split”) of the Company’s issued and outstanding ordinary shares, par value NIS 0.1 per share (the “Ordinary Shares”), at the ratio of 10-for-1, such that each ten (10) Ordinary Shares shall be consolidated into one (1) Ordinary Share.

Company Contact

CEO
Alon Seri-Levy
CFO
Gilad Mamlok
Investor Relations
Patricia L. Bank, Westwicke Partners · 415-513-1284 · patti.bank@westwicke.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »